AChR
Acetylcholine, a major neurotransmitter of the parasympathetic and sympathetic nervous systems, was discovered in the early 1900s. It is a small-molecule neurotransmitter and neuromodulator with roles in the peripheral and central nervous systems and is associated with the sympathetic and parasympathetic components of the autonomic nervous system. ACh is also the main signal used by motor neurons to activate smooth muscle and, more recently, has been shown to play an important part in signaling from the nervous system to the immune system. ACh is typically released from presynaptic terminals into the synaptic cleft of neurons for transmission of the signal to acetylcholine receptors (AChRs) on the post-synaptic cell.
ACh binds to two subclasses of AChR: nicotinic and muscarinic AChRs, which are historically distinguished by their ability to bind either nicotine or muscarine (natural but nonendogenous agonists). ACh signaling is also regulated by the enzyme acetylcholine esterase [AChE (butylChE present in plasma)] which is present within the synaptic cleft or neuromuscular junctions and catalyzes the hydrolysis of ACh into acetate and choline. This neurotransmitter/modulator, in many instances, works locally at close range (synaptic clefts), but the cholinergic tone of its receptors (propensity to signal) can be regulated by endogenous levels of acetylcholine or exogenous ligands
References:
1.VanPatten S,et al. Drug Discov Today. 2017 Jan;22(1):97-104.
ACh binds to two subclasses of AChR: nicotinic and muscarinic AChRs, which are historically distinguished by their ability to bind either nicotine or muscarine (natural but nonendogenous agonists). ACh signaling is also regulated by the enzyme acetylcholine esterase [AChE (butylChE present in plasma)] which is present within the synaptic cleft or neuromuscular junctions and catalyzes the hydrolysis of ACh into acetate and choline. This neurotransmitter/modulator, in many instances, works locally at close range (synaptic clefts), but the cholinergic tone of its receptors (propensity to signal) can be regulated by endogenous levels of acetylcholine or exogenous ligands
References:
1.VanPatten S,et al. Drug Discov Today. 2017 Jan;22(1):97-104.
Cell Cycle/DNA Damage
ABC(12)
AChR(104)
Antifolate(12)
ATM/ATR(26)
Aurora Kinase(51)
CLK(15)
c-Myc(22)
DHFR(16)
DNA Alkylator(34)
DNA gyrase(11)
DNA Repair Protein(21)
DNA/RNA Synthesis(187)
DNA-PK(15)
GPR(97)
HDAC(152)
Hec1/Nek2(9)
Integrin(77)
LIM Kinase (LIMK)(7)
Mps1/TTK(2)
Nucleoside Antimetabolite/Analog(48)
Other Targets(4)
PAK(13)
PARP(67)
PLK(26)
Potassium Channel(146)
RAD51(1)
Rho(16)
ROCK(42)
Telomerase(12)
Topoisomerase(88)
Wee1(7)
AChR
-
Metixene hydrochloride hydrate
产品货号 : M37950
cas no: 7081-40-5
Metixene (Piperidine) hydrochloride hydrate 是一种抗胆碱能和抗帕金森剂。Metixene hydrochloride hydrate 可有效抑制苯甲酸奎宁环 (QNB) 与毒蕈碱受体的结合,IC50 值和 Ki 值分别为 55 nM 和 15 nM。 Metixene hydrochloride hydrate 可用于帕金森病的研究。 -
Velufenacin
产品货号 : M37659
cas no: 1648737-78-3
Velufenacin 是毒蕈碱型受体 (muscarinic receptor) 的拮抗剂。 -
SSR 180
产品货号 : M37507
cas no: 298198-52-4
SSR 180 is a potent and subtype-selective α7 agonist with applications in the study of Alzheimer;s disease and schizophrenia. -
TZ3O
产品货号 : M37043
cas no: 2218754-19-7
TZ3O is an anticholinergic compound with neuroprotective activity.TZ3O ameliorates memory impairment and cognitive decay in Scopolamine-induced Alzheimer's type model in rats, and can be used in the study of Alzheimer's disease. -
hBChE-IN-2
产品货号 : M36924
cas no: 2923366-36-1
hBChE-IN-2 (compound 15d) 是一种丁酰胆碱酯酶 (BChE) 抑制剂 (IC50 为 0.62 μM) 和大麻素受体 2 (CB2R) 激动剂。hBChE-IN-2 具有神经保护活性。